Skip to main content
Premium Trial:

Request an Annual Quote

BioNano Genomics Raises $5M

NEW YORK (GenomeWeb) – Genome mapping company BioNano Genomics said in a regulatory filing that it raised $5 million toward a targeted $6.1 million financing round.

In a document filed with the US Securities and Exchange Commission last week, BioNano said that the type of securities offered included debt; option, warrant, or other rights to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to acquire security.

The firm did not disclose the investors in the round or say how proceeds would be used. Through a spokesperson, the company declined to comment.

In October, the San Diego firm raised $10 million to support the development and commercialization of its human genome analysis platform called Irys, which images extremely long molecules for the observation of native genomic structure.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.